NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Capital Reinvestment Ratio
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Capital Reinvestment Ratio of 0.00x as of December 2022, meaning it reinvests 0% of its operating cash flow ($29.19 Million) in capital expenditures ($109.43K). See NAMS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NewAmsterdam Pharma Company N.V. Ordinary Shares Capital Reinvestment Ratio (2022–2022)
This chart tracks NewAmsterdam Pharma Company N.V. Ordinary Shares's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)
Year-by-year Capital Reinvestment Ratio for NewAmsterdam Pharma Company N.V. Ordinary Shares from 2022 to 2022. For live market cap and broader valuation context, see NAMS stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.02x | $10.66 Million | $221.00K | — |